Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes have?
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes has 309 citations in the OpenAlex counts ScholarIQ stores.
When was Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes published?
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes has 2012 year in the ScholarIQ index.
What is the open-access status of Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes?
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes has hybrid oa status in the ScholarIQ index.
What is the DOI of Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes?
The DOI for Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes is on the source record.
What is the PMID of Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes?
The PMID for Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes is on the source record.
What is the OpenAlex record for Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes?
The OpenAlex for Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes is on the source record.